In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Nizoral, Extina, Xolegel, Kuric, Ketoconazole Drug Master File in Korea (Nizoral, Extina, Xolegel, Kuric, Ketoconazole KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Nizoral, Extina, Xolegel, Kuric, Ketoconazole. The MFDS reviews the Nizoral, Extina, Xolegel, Kuric, Ketoconazole KDMF as part of the drug registration process and uses the information provided in the Nizoral, Extina, Xolegel, Kuric, Ketoconazole KDMF to evaluate the safety and efficacy of the drug.
After submitting a Nizoral, Extina, Xolegel, Kuric, Ketoconazole KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Nizoral, Extina, Xolegel, Kuric, Ketoconazole API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Nizoral, Extina, Xolegel, Kuric, Ketoconazole suppliers with KDMF on PharmaCompass.